Driven by Results, Defined by Innovation
Our Team
Professor Dr. Nurulfiza Mat Isa
Founder
Background History
Prof. Dr. Nurulfiza Mat Isa
Founder, Nuevogenix Sdn Bhd
Prof. Dr. Nurulfiza Mat Isa is the Founder of Nuevogenix Sdn Bhd and a highly accomplished scientist in biotechnology and microbiology. She earned her BSc in Biotechnology and PhD in Molecular Biology from Universiti Putra Malaysia. With extensive experience in microbial research, pathogen characterization, and applied biotechnology solutions, she has been at the forefront of next-generation vaccine research.
Her work spans the development of innovative vaccine strategies and advanced microbial technologies, with a strong focus on translational research addressing global veterinary and microbial challenges. Prof. Dr. Nurulfiza provides strategic scientific leadership at Nuevogenix, guiding its research direction, innovation pipeline, and long-term vision to deliver impactful, science-driven solutions for animal, plant, and human health.
Professor Dato’ Dr. Mohd Hair Bejo
Co – Founder
Background History
Prof. Dato’ Dr. Mohd Hair Bejo
Co-Founder, Nuevogenix Sdn Bhd
Prof. Dato’ Dr. Mohd Hair Bejo is a distinguished avian and veterinary pathologist and Co-Founder of Nuevogenix Sdn Bhd, with over 20 years of expertise in veterinary pathology and vaccine development. He earned his Doctor of Veterinary Medicine from Universiti Putra Malaysia and PhD in Veterinary Pathology from University of Liverpool, United Kingdom.
He is the inventor of two licensed poultry vaccines currently in commercial use, demonstrating his ability to translate scientific discoveries into practical, life-saving solutions. Prof. Dato’ Dr. Hair Bejo brings deep clinical, pathological, and regulatory insight to Nuevogenix, ensuring that vaccine innovations are scientifically robust, industry-ready, and aligned with real-world veterinary needs.
Dr. Siti Nur Bahiyah Azli @ Mohd Azli
Co-founder / Chief Executive Officer
Background History
Dr. Siti Nur Bahiyah Azli
Director & Chief Executive Officer, Nuevogenix Sdn Bhd
Dr. Siti Nur Bahiyah Azli is the Director and CEO of Nuevogenix Sdn Bhd, with expertise in biomedical science, bioinformatics, and systems biology. She earned her BSc in Biomedical Science from University of Edinburgh, United Kingdom, and PhD in Bioinformatics & Systems Biology from Unviersiti Putra Malaysia.
Her specialization in computational genomics, precision vaccine design, and systems-level analysis of host–pathogen interactions enables the integration of advanced computational and molecular approaches to accelerate vaccineand recombinant bio-based product development. Dr. Siti Nur Bahiyah bridges research, biotechnology, and commercialization, leading Nuevogenix’s strategic growth and ensuring that innovations are technologically advanced, scalable, and market-ready.
Our Mission & Vision
At Nuevogenix, we combine science and innovation to create next-generation biotech solutions that drive progress and sustainability.
Our Mission
To pioneer accessible programmable bioengineering solutions that advance animal, plant, and human health through integrated advanced biotechnology for disease prevention, control, and diagnosis
Our Vision
To enable precision bioengineering by integrating CRISPR, bioinformatics, next-generation sequencing, and molecular engineering, bridging research and commercialization across animal, plant, and human applications
Book an Appointment
with Our Experts
Take the next step toward innovation. Schedule a consultation with our team to discuss research collaborations, biotech solutions, or tailored vaccine development services. Our specialists are ready to guide you with expert insights and customized strategies designed to meet your goals.